Literature DB >> 8290720

Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review.

A M Freedman1, A J Sanyal, J Tisnado, P E Cole, M L Shiffman, V A Luketic, P P Purdum, M D Darcy, M P Posner.   

Abstract

It is generally accepted that the transjugular intrahepatic portosystemic shunt (TIPS) procedure has lower morbidity and mortality rates than those of surgical shunting. Nevertheless, complications occur. The authors have reviewed their experience and that of other institutions in compiling an extensive list of complications. Complications are categorized according to those related to transhepatic needle puncture, transvenous access to the portal vein, portal venous cannulation, the stent, the puncture site, portosystemic shunting, and contrast material. Excluding hepatic encephalopathy and delayed stenosis or occlusion of the shunt, an overall complication rate of less than 10% can be expected for TIPS. The prevalence of aggravated or new cases of encephalopathy is 5%-35%, and over the long term, up to 75% of shunts may undergo stenosis or occlusion. The direct procedural mortality rate is less than 2%, and the 30-day mortality rate ranges from 4% to 45%, depending on several factors. The role to which TIPS is relegated will be influenced by the long-term success rate in the prevention of recurrent variceal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290720     DOI: 10.1148/radiographics.13.6.8290720

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  52 in total

Review 1.  Current status of transjugular intrahepatic portosystemic shunts.

Authors:  N H Patel; N Chalasani; R M Jindal
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

Review 2.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

3.  Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.

Authors:  Edward Wolfgang Lee; Andrew Kuei; Sammy Saab; Ronald W Busuttil; Francisco Durazo; Steven-Huy Han; Mohamed M El-Kabany; Justin P McWilliams; Stephen T Kee
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

4.  Post-TIPS hepatic encephalopathy treated by occlusion balloon-assisted retrograde embolization of a coexisting spontaneous splenorenal shunt.

Authors:  Y Shioyama; K Matsueda; K Horihata; M Kimura; N Nishida; K Kishi; M Terada; M Sato; R Yamada
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

5.  Portal vein thrombosis.

Authors:  Hector Rodriguez-Luna; Hugo E Vargas
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

6.  Prophylactic antibiotic guidelines in modern interventional radiology practice.

Authors:  Eunice Moon; Matthew D B S Tam; Raghid N Kikano; Karunakaravel Karuppasamy
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

7.  Stent-Graft Displacement during TIPS Reintervention.

Authors:  Brian Funaki
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

8.  Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension.

Authors:  Kai Liu; Xin-Xin Fan; Xu-Lin Wang; Chang-Sheng He; Xing-Jiang Wu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

9.  Inadvertent arteriovenous stenting during transjugular intrahepatic portosystemic shunt procedure and the importance of hepatic artery perfusion.

Authors:  P M Pattynama; B van Hoek; L J Kool
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

10.  Direct intrahepatic portacaval shunt: an experimental study.

Authors:  Jian-Jun Luo; Zhi-Ping Yan; Kang-Rong Zhou; Sheng Qian
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.